Market Overview:
The global C13 stable isotope labeled biomolecules market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for medical C13 stable isotope labeled biomolecules and rising application of these molecules in scientific research, medical, and industrial applications. North America is expected to dominate the global C13 stable isotope labeled biomolecules market during the forecast period, followed by Europe and Asia Pacific. However, Asia Pacific is projected to witness highest growth rate during the forecast period owing to increasing investments by major players in this region and rising demand for these molecules from emerging countries such as China and India.
Product Definition:
C13 Stable Isotope Labeled Biomolecules are biomolecules that have been labeled with the stable isotope carbon-13. These molecules are used to study the structure and function of proteins, enzymes, and other biomolecules. The use of C13 Stable Isotope Labeled Biomolecules can help researchers to better understand how these molecules work and how they interact with each other.
Medical C13 Stable Isotope Labeled Biomolecules:
Medical C13 stable isotope labeled biomolecules are used for the purpose of in-vitro kinetic analysis of proteins and peptide hormones. These molecules are extensively applied in research activities aimed at understanding the mechanism and/or nature of biological processes taking place within a living system.
Others:
Others are the other stable isotopes that can be used as a source of carbon in biological molecules. The most common ones are 13C, 15N, and 18O. Others have applications in clinical diagnostics and research related to metabolism, nutrition & dietetics, drug discovery & development along with being useful for biotechnology purposes.
Application Insights:
The global market is segmented by application into scientific research, medical, industrial and other applications. The other applications include food and agriculture, environmental testing and others. The demand for labeling stable isotopes for use in research on the metabolic processes of living organisms is expected to drive the growth of this segment over the forecast period owing to its increasing usage in studies related to gene expression, cell proliferation & death pathway activity as well as protein synthesis.
C13 labeled glucose can be used not only in studying cellular metabolism but also in tracking down a variety of physiological changes such as intracellular acidosis or alkalosis that may occur during different stages of disease progression or due to drug treatment. These factors are anticipated to increase product utilization across various research projects thereby driving its demand worldwide over the forecast period.
Medical application dominated this market with a share estimated at around 60% globally followed by industrial at around 40% globally (in terms of revenue).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of C13 stable isotope labeled biomolecules manufacturers and suppliers coupled with high R&D investment by companies has resulted in North America’s dominance.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure, growing patient awareness levels coupled with government initiatives pertaining to utilization of advanced diagnostic technologies for cancer detection are some factors driving this regional market growth. Moreover, availability of skilled professionals at relatively lower costs compared to developed regions will also help boost Asia Pacific’s development over the next eight years (28).
Growth Factors:
- Increasing demand for precision medicine
- Rising prevalence of chronic diseases
- Growing number of clinical trials
- Technological advancements in mass spectrometry
- Proliferation of contract research organizations
Scope Of The Report
Report Attributes
Report Details
Report Title
C13 Stable Isotope Labeled Biomolecules Market Research Report
By Type
Medical C13 Stable Isotope Labeled Biomolecules, Others
By Application
Scientific Research, Medical, Industrial, Others
By Companies
Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals, Icon Isotopes, Medical Isotopes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global C13 Stable Isotope Labeled Biomolecules Market Report Segments:
The global C13 Stable Isotope Labeled Biomolecules market is segmented on the basis of:
Types
Medical C13 Stable Isotope Labeled Biomolecules, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Scientific Research, Medical, Industrial, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cambridge Isotope Laboratories
- Sigma-Aldrich
- Thermo Fisher Scientific
- LGC Standards
- Toronto Research Chemicals
- IsoLife BV
- WITEGA Laboratorien
- Omicron Biochemicals
- Icon Isotopes
- Medical Isotopes
Highlights of The C13 Stable Isotope Labeled Biomolecules Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical C13 Stable Isotope Labeled Biomolecules
- Others
- By Application:
- Scientific Research
- Medical
- Industrial
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the C13 Stable Isotope Labeled Biomolecules Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
C13 stable isotope labeled biomolecules are molecules that have been tagged with a C13 atom. This allows scientists to track the molecule's movements and interactions in detail.
Some of the key players operating in the c13 stable isotope labeled biomolecules market are Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals, Icon Isotopes, Medical Isotopes.
The c13 stable isotope labeled biomolecules market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 C13 Stable Isotope Labeled Biomolecules Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 C13 Stable Isotope Labeled Biomolecules Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 C13 Stable Isotope Labeled Biomolecules Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the C13 Stable Isotope Labeled Biomolecules Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global C13 Stable Isotope Labeled Biomolecules Market Size & Forecast, 2020-2028
4.5.1 C13 Stable Isotope Labeled Biomolecules Market Size and Y-o-Y Growth
4.5.2 C13 Stable Isotope Labeled Biomolecules Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Medical C13 Stable Isotope Labeled Biomolecules
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Scientific Research
6.2.2 Medical
6.2.3 Industrial
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global C13 Stable Isotope Labeled Biomolecules Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Medical C13 Stable Isotope Labeled Biomolecules
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Scientific Research
9.10.2 Medical
9.10.3 Industrial
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Medical C13 Stable Isotope Labeled Biomolecules
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Scientific Research
10.10.2 Medical
10.10.3 Industrial
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Medical C13 Stable Isotope Labeled Biomolecules
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Scientific Research
11.10.2 Medical
11.10.3 Industrial
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Medical C13 Stable Isotope Labeled Biomolecules
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Scientific Research
12.10.2 Medical
12.10.3 Industrial
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Medical C13 Stable Isotope Labeled Biomolecules
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Scientific Research
13.10.2 Medical
13.10.3 Industrial
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 C13 Stable Isotope Labeled Biomolecules Market: Competitive Dashboard
14.2 Global C13 Stable Isotope Labeled Biomolecules Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cambridge Isotope Laboratories
14.3.2 Sigma-Aldrich
14.3.3 Thermo Fisher Scientific
14.3.4 LGC Standards
14.3.5 Toronto Research Chemicals
14.3.6 IsoLife BV
14.3.7 WITEGA Laboratorien
14.3.8 Omicron Biochemicals
14.3.9 Icon Isotopes
14.3.10 Medical Isotopes
